SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-180373
Filing Date
2023-06-30
Accepted
2023-06-30 16:01:56
Documents
16
Period of Report
2023-06-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d506648d8k.htm   iXBRL 8-K 28387
2 EX-1.1 d506648dex11.htm EX-1.1 212752
3 EX-5.1 d506648dex51.htm EX-5.1 12856
7 GRAPHIC g506648g0630015539452.jpg GRAPHIC 1827
8 GRAPHIC g506648g50j76.jpg GRAPHIC 4268
  Complete submission text file 0001193125-23-180373.txt   450563

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA idya-20230626.xsd EX-101.SCH 2857
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20230626_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20230626_pre.xml EX-101.PRE 11712
10 EXTRACTED XBRL INSTANCE DOCUMENT d506648d8k_htm.xml XML 3482
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38915 | Film No.: 231061590
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences